FDA Approves Lenvima (lenvatinib) for First-line Treatment of Unresectable Hepatocellular Carcinoma (HCC)
Woodcliff Lake, NJ and Kenilworth, NJ, Aug. 16, 2018 – Eisai Inc. and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, annou
					    
			    
				  
				  
					
				 
					
					
					  
					  
					  Eating Before Early Workout Helps Burn Carbs
FRIDAY, Aug. 17, 2018 -- If you exercise in the morning, it may be a good idea to eat breakfast first.
A small British study finds that having breakfast before a morning workout triggers the body to burn mo
					    
			    
				  
				  
					
				 
					
					
					  
					  
					  FDA Approves Cequa
Sun Pharma Announces FDA Approval of Cequa (cyclosporine) Ophthalmic Solution to Treat Dry Eye Disease
MUMBAI, India & PRINCETON, N.J.--(BUSINESS WIRE)-- August 16, 2018 -- Sun Pharmaceutical Industries Ltd. (Reuters:SUN.BO, Bloomberg
					    
			    
				  
				  
					
				 
					
					
					  
					  
					  Infection Prevention Differs Between Small, Large Hospitals
THURSDAY, Aug. 9, 2018 -- Small and large hospitals differ in infection preventionist (IP) staffing and infection prevention and control (IPC) resources, according to a study published in the Au
					    
			    
				  
				  
					
				 
					
					
					  
					  
					  FDA Approves Arakoda
FDA Approves Arakoda (tafenoquine) for the Prevention of Malaria
WASHINGTON, Aug. 9, 2018 /PRNewswire/ -- 60 Degrees Pharmaceuticals (60P) announced today the U.S. Food and Drug Administration (FDA) approval of Arakoda (tafenoquine)
					    
			    
				  
				  
					
				 
					
					
					  
					  
					  FDA Approves Poteligeo
FDA Approves Poteligeo (mogamulizumab-kpkc) for Mycosis Fungoides and Sézary Syndrome
August 8, 2018 -- The U.S. Food and Drug Administration today approved Poteligeo (mogamulizumab-kpkc) injection for intravenous use for the tr
					   